Atrial fibrillation follow-up investigation of rhythm management - The AFFIRM study design

American Journal of Cardiology

Volumn 79, Issue 9, 1997, Pages 1198-1202

  Greene, H Leon ^a  

^a Stat and Epidemiol Res Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; DISOPYRAMIDE; FLECAINIDE; MORACIZINE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL;

ALGORITHM; ANTICOAGULATION; ARTICLE; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG COST; HEART ATRIUM FIBRILLATION; HEART PACING; HUMAN; MULTICENTER STUDY; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STROKE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CATHETER ABLATION; CEREBRAL HEMORRHAGE; CEREBROVASCULAR DISORDERS; ELECTROCARDIOGRAPHY, AMBULATORY; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEART ARREST; HEART RATE; HEMORRHAGE; HUMANS; MULTICENTER STUDIES; PATIENT SELECTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; RESEARCH DESIGN; RISK FACTORS; SURVIVAL RATE;

EID: 0001514088     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00082-9     Document Type: Article

References (14)

1. NHLBI Working Group on Atrial Fibrillation. Atrial fibrillation: current understandings and research imperatives. J Am Coll Cardiol 1993;22:1830-1834.
2. Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Ann Intern Med 1992;116:1-5.
3. Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. Ann Intern Med 1992;116:6-12.
4. Cox JL, Schuessler RB, D'Agostino HJ Jr., Stone CM, Chang BC, Cain ME, Corr PB, Boineau JP. The surgical treatment of atrial fibrillation III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 1991;101:569-583.
5. Dreifus LS, Fisch C, Griffin JC, Gillette PC, Mason JW, Parsonnet V. Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Pacemaker Implantation). Circulation 1991;84:455-467.
6. Laupacis A, Albers G, Dalen J, Dunn M, Feinberg W, Jacobson A. Antithrombotic therapy in atrial fibrillation. Chest 1995;108:352S-359S.
7. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975;12:189-198.
8. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-Item Short Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66.
9. Ferrans CE, Powers MJ. Quality of life Index: development and psychometric properties. Adv Nurs Sci 1985;8:15-24.
10. Shin JH. Sample size calculation for complex clinical trials with survival endpoints. Controlled Clinical Trials 1995;16:395-407.
11. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation. Stroke prevention in atrial fibrillation II study. Lancet 1994;343:687-691.
12. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-667.
13. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979;35:549-556.
14. Hallstrom AP, Litwin P, Weaver DW. A method of assigning scores to the components of a composite outcome: an example from the MITI trial. Controlled Clinical Trials 1992;13:148-155.